RFCA
NPTN

R&F Capital Advisors’s NEOPHOTONICS CORP NPTN Stock Holding History

R&F Capital Advisors’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-13,980
Closed -$151K – 854
2016
Q4 		$151K Buy
+13,980
New +$186K 0.05% 433

Other funds holding NPTN

OMC
Oak Management Corp Wilton, Connecticut $3.24M AUM 83.68% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

R&F Capital Advisors's NPTN Position: Q1 2017 in Review

R&F Capital Advisors sold out of NEOPHOTONICS CORP (NPTN) in Q1 2017, closing a stake of 13,980 shares — an estimated $151K sold.

R&F Capital Advisors first reported a position in NPTN in Q4 2016 and held it in 1 quarter. The position peaked at $151K in Q4 2016. 126 funds tracked by Wall St. Rank hold NPTN as of Q1 2017.

  • R&F Capital Advisors reported no remaining NEOPHOTONICS CORP position as of Q1 2017 after selling out during the quarter.
  • R&F Capital Advisors sold 13,980 NEOPHOTONICS CORP shares in Q1 2017, an estimated $151K.
  • R&F Capital Advisors first reported a position in NEOPHOTONICS CORP in Q4 2016 and held it in 1 quarter.
  • R&F Capital Advisors's NEOPHOTONICS CORP position peaked at $151K in Q4 2016.
  • 126 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q1 2017.

Based on R&F Capital Advisors's 13F filing for Q1 2017, filed 15 May 2017.